Page last updated: 2024-09-04

docetaxel anhydrous and Pseudomyxoma Peritonei

docetaxel anhydrous has been researched along with Pseudomyxoma Peritonei in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, LF; Ji, ZH; Li, XB; Li, Y; Lin, YL; Ma, R; Yan, FC; Yang, ZR; Zhang, J1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Pseudomyxoma Peritonei

ArticleYear
Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:4 Pt A

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Blood Loss, Surgical; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Erythrocyte Transfusion; Female; Humans; Hyperthermia, Induced; Intestinal Fistula; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Postoperative Complications; Postoperative Hemorrhage; Pseudomyxoma Peritonei; Retrospective Studies; Risk Factors; Young Adult

2020